Scedosporium apiospermum keratitis

Revista Iberoamericana de Micologia

Volumn 20, Issue 2, 2003, Pages 68-70

  Linares Sicilia, Ma José ^a   Santos Lacomba, Manuel ^b   Solís Cuesta, Francisco ^a   Sánchez Pedraza, Rafael ^b   Nievas Gómez, Trinidad ^b   Casal Román, Manuel ^a  

^a Universidad de Cordoba   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Amphotericin B; Mycotic keratitis; Scedosporium apiospermum

Indexed keywords

AMPHOTERICIN B; CEFAZOLIN; CYCLOPENTOLATE; FLUOROMETHOLONE; VANCOMYCIN;

AGED; ARTICLE; CASE REPORT; CORNEA ULCER; FUNGUS HYPHAE; HUMAN; KERATITIS; MALE; SCEDOSPORIUM APIOSPERMUM; TISSUE CULTURE; TREATMENT OUTCOME;

AGED; EYE INFECTIONS, FUNGAL; HUMANS; KERATITIS; MALE; SCEDOSPORIUM;

FUNGI; PSEUDALLESCHERIA BOYDII; SCEDOSPORIUM;

EID: 0242475009     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bhermi G, Gillespie I, Mathalone B. Scedosporium (Pseudallescheria) fungal infection of a sponge explant. Eye 2000; 14: 247-249.
2. Surg Sridhar MS, Garg P, Bausal AK, Sharma S. Fungal keratitis after laser in situ keratomileusis. J Cataract Refract 2000; 26: 613-615.
3. Kwon Chung KJ, Bennett JE. Infections due to miscellaneous molds. In: Kwon Chung KJ, Bennett JE (Eds.) Medical Mycology. Philadelphia, Lea & Febiger, 1992; 743-753.
4. Guého E, De Hoog GS. Taxonomy of the medical species of Pseudallescheria and Scedosporium. J Mycol Med 1991; 118: 3-9.
5. Sterinert RF, McColgin AZ, White A, Horrsburgh GM. Diffuse interface keratitis after laser in situ keratomileusis (LASIK): a nonspecific syndrome. Am J Ophthalmol 2000; 129: 380-381.
6. Del Palacio A, Pérez-Blázquez E, Cuétara MS, García Bravo M, Criado-Gimeno C, Noriega AR. Keratomycosis due to Scedosporium apiospermum. Mycoses 1991; 34: 483-487.
7. National Committee for Clinical Laboratory Standards (NCCLS): Reference method for broth dilution antifungical susceptibility testing of conidium-forming filamentous fungi; Proposed standard NCCLS, document M38-P Wayne, Pa, NCCLS, 1998.
8. Espinel-Ingroff A, Bartleett M, Bowden R, et al. Multicenter evaluation of proposed standardized procedure for antifungical susceptibility testing of filamentous fungi. J Clin Microbiol 1997; 35: 139-143.
9. Kobayashi GS, Spiteer DE. Testing of organisms for susceptility to triazoles: is it justified? Eur J Clin Microbiol 1989; 8: 387-389
10. Cunningham R, Mitchell DC. Amphotericin B responsive Scedosporium apiospermum in a patient with acute myeloid leukaemia. J Clin Pathol 1996; 49: 93-94.
11. Dworzack DL, Clark RB, Borkowski Jr WJ, et al. Pseudallescheria boydii brain abscess: association with near drowning and efficacy of high-dose, prolonged miconazole therapy in patients with multiple abscesses. Medicine 1989; 68: 218-224.
12. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature. Mycopathologia 2001; 150: 101-115.
13. Hoffman HL, Rathbun RC. Review of the safety and efficacy of voriconazole. Expert Opin Investig Drugs 2002; 11: 409-429.
14. Girmenia C, Luzi G. Monaco M. Martinez P. Use of voriconazole in treatment of Scedosporium apiospermum infection. J Clin Microbiol 1998; 36: 1436-1438
15. Walsh TJ, Peter J, McGough DA, Forthergill AW, Rinaldi MG, Pizzo PA. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob Agents Chemother 1995; 39: 1361-1364.
16. Nulens E, Eggink C, Verweij PE. Combination therapy for keratitis by the fungus Scedosporium. Cornea 2003; 22: 92.